Hypaque Meglumine and Inotuzumab ozogamicin Intravenous
Determining the interaction of Hypaque Meglumine and Inotuzumab ozogamicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diatrizoate
Brand name: Cystografin, Cystografin-Dilute, Gastrografin, MD-76 R, MD-Gastroview
Synonyms: Hypaque Meglumine (Intravenous)
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hypaque Meglumine-Inova
- Hypaque Meglumine-Inova 4/1 topical
- Hypaque Meglumine-Inova 8/2 topical
- Hypaque Meglumine-Inova ACT
- Hypaque Meglumine-Inrebic
- Hypaque Meglumine-Inspra
- Inotuzumab ozogamicin Intravenous-Hypaque-76
- Inotuzumab ozogamicin Intravenous-Hypaque-Cysto
- Inotuzumab ozogamicin Intravenous-Hyper-Sal inhalation
- Inotuzumab ozogamicin Intravenous-Hyperhep B
- Inotuzumab ozogamicin Intravenous-HyperHEP B S/D
- Inotuzumab ozogamicin Intravenous-Hyperlyte CR